Stocktoria
Oric Pharmaceuticals, Inc. ORIC
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-04-24
Chart by TradingView
3/9
Piotroski F — financial health
12.88
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$143.0M | -$142.9M | -$110.8M | -$91.8M | -$78.9M |
| Net income | -$129.5M | -$127.8M | -$100.7M | -$89.1M | -$78.7M |
| Operating cash flow | -$111.0M | -$112.7M | -$85.7M | -$75.1M | -$59.5M |
| Free cash flow | -$111.7M | -$113.8M | -$86.5M | -$77.2M | -$60.5M |
| Total assets | $408.9M | $274.1M | $252.0M | $247.2M | $298.6M |
| Total liabilities | $24.5M | $31.0M | $27.9M | $24.8M | $25.7M |
| Shareholders' equity | $384.4M | $243.1M | $224.1M | $222.4M | $273.0M |
| Ratios | |||||
| Return on assets | -31.7% | -46.6% | -40.0% | -36.1% | -26.4% |
| Return on equity | -33.7% | -52.6% | -44.9% | -40.1% | -28.8% |
| Debt / equity | — | — | — | — | 0.04× |
| Current ratio | 14.13 | 10.56 | 10.39 | 13.68 | 15.87 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 12.88 (safe)
- Working capital / assets 0.656
- Retained earnings / assets -1.693
- EBIT / assets -0.35
- Equity / liabilities 15.67
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001796280 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.